Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and gαq overexpression-induced heart failure

Dao Fu Dai, Simon C. Johnson, Jason J. Villarin, Michael T. Chin, Madeline Nieves-Cintrón, Tony Chen, David J. Marcinek, Gerald W. Dorn, Y. James Kang, Tomas A. Prolla, Luis F. Santana, Peter S. Rabinovitch

Research output: Contribution to journalArticle

260 Citations (Scopus)

Abstract

Rationale: Mitochondrial dysfunction has been implicated in several cardiovascular diseases; however, the roles of mitochondrial oxidative stress and DNA damage in hypertensive cardiomyopathy are not well understood. Objective: We evaluated the contribution of mitochondrial reactive oxygen species (ROS) to cardiac hypertrophy and failure by using genetic mouse models overexpressing catalase targeted to mitochondria and to peroxisomes. Methods and results: Angiotensin II increases mitochondrial ROS in cardiomyocytes, concomitant with increased mitochondrial protein carbonyls, mitochondrial DNA deletions, increased autophagy and signaling for mitochondrial biogenesis in hearts of angiotensin II-treated mice. The causal role of mitochondrial ROS in angiotensin II-induced cardiomyopathy is shown by the observation that mice that overexpress catalase targeted to mitochondria, but not mice that overexpress wild-type peroxisomal catalase, are resistant to cardiac hypertrophy, fibrosis and mitochondrial damage induced by angiotensin II, as well as heart failure induced by overexpression of Gαq. Furthermore, primary damage to mitochondrial DNA, induced by zidovudine administration or homozygous mutation of mitochondrial polymerase γ, is also shown to contribute directly to the development of cardiac hypertrophy, fibrosis and failure. Conclusions: These data indicate the critical role of mitochondrial ROS in cardiac hypertrophy and failure and support the potential use of mitochondrial-targeted antioxidants for prevention and treatment of hypertensive cardiomyopathy.

Original languageEnglish (US)
Pages (from-to)837-846
Number of pages10
JournalCirculation Research
Volume108
Issue number7
DOIs
StatePublished - Apr 1 2011
Externally publishedYes

Fingerprint

Cardiomegaly
Angiotensin II
Reactive Oxygen Species
Oxidative Stress
Heart Failure
Cardiomyopathies
Catalase
Mitochondrial DNA
Mitochondria
Fibrosis
Peroxisomes
Zidovudine
Mitochondrial Proteins
Genetic Models
Autophagy
Organelle Biogenesis
Cardiac Myocytes
DNA Damage
Cardiovascular Diseases
Antioxidants

Keywords

  • angiotensin
  • cardiomyopathy
  • heart failure
  • mitochondria
  • reactive oxygen species

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and gαq overexpression-induced heart failure. / Dai, Dao Fu; Johnson, Simon C.; Villarin, Jason J.; Chin, Michael T.; Nieves-Cintrón, Madeline; Chen, Tony; Marcinek, David J.; Dorn, Gerald W.; Kang, Y. James; Prolla, Tomas A.; Santana, Luis F.; Rabinovitch, Peter S.

In: Circulation Research, Vol. 108, No. 7, 01.04.2011, p. 837-846.

Research output: Contribution to journalArticle

Dai, DF, Johnson, SC, Villarin, JJ, Chin, MT, Nieves-Cintrón, M, Chen, T, Marcinek, DJ, Dorn, GW, Kang, YJ, Prolla, TA, Santana, LF & Rabinovitch, PS 2011, 'Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and gαq overexpression-induced heart failure', Circulation Research, vol. 108, no. 7, pp. 837-846. https://doi.org/10.1161/CIRCRESAHA.110.232306
Dai, Dao Fu ; Johnson, Simon C. ; Villarin, Jason J. ; Chin, Michael T. ; Nieves-Cintrón, Madeline ; Chen, Tony ; Marcinek, David J. ; Dorn, Gerald W. ; Kang, Y. James ; Prolla, Tomas A. ; Santana, Luis F. ; Rabinovitch, Peter S. / Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and gαq overexpression-induced heart failure. In: Circulation Research. 2011 ; Vol. 108, No. 7. pp. 837-846.
@article{62ca4cc91a7c47ee85d1323bd05c4dc9,
title = "Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and gαq overexpression-induced heart failure",
abstract = "Rationale: Mitochondrial dysfunction has been implicated in several cardiovascular diseases; however, the roles of mitochondrial oxidative stress and DNA damage in hypertensive cardiomyopathy are not well understood. Objective: We evaluated the contribution of mitochondrial reactive oxygen species (ROS) to cardiac hypertrophy and failure by using genetic mouse models overexpressing catalase targeted to mitochondria and to peroxisomes. Methods and results: Angiotensin II increases mitochondrial ROS in cardiomyocytes, concomitant with increased mitochondrial protein carbonyls, mitochondrial DNA deletions, increased autophagy and signaling for mitochondrial biogenesis in hearts of angiotensin II-treated mice. The causal role of mitochondrial ROS in angiotensin II-induced cardiomyopathy is shown by the observation that mice that overexpress catalase targeted to mitochondria, but not mice that overexpress wild-type peroxisomal catalase, are resistant to cardiac hypertrophy, fibrosis and mitochondrial damage induced by angiotensin II, as well as heart failure induced by overexpression of Gαq. Furthermore, primary damage to mitochondrial DNA, induced by zidovudine administration or homozygous mutation of mitochondrial polymerase γ, is also shown to contribute directly to the development of cardiac hypertrophy, fibrosis and failure. Conclusions: These data indicate the critical role of mitochondrial ROS in cardiac hypertrophy and failure and support the potential use of mitochondrial-targeted antioxidants for prevention and treatment of hypertensive cardiomyopathy.",
keywords = "angiotensin, cardiomyopathy, heart failure, mitochondria, reactive oxygen species",
author = "Dai, {Dao Fu} and Johnson, {Simon C.} and Villarin, {Jason J.} and Chin, {Michael T.} and Madeline Nieves-Cintr{\'o}n and Tony Chen and Marcinek, {David J.} and Dorn, {Gerald W.} and Kang, {Y. James} and Prolla, {Tomas A.} and Santana, {Luis F.} and Rabinovitch, {Peter S.}",
year = "2011",
month = "4",
day = "1",
doi = "10.1161/CIRCRESAHA.110.232306",
language = "English (US)",
volume = "108",
pages = "837--846",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and gαq overexpression-induced heart failure

AU - Dai, Dao Fu

AU - Johnson, Simon C.

AU - Villarin, Jason J.

AU - Chin, Michael T.

AU - Nieves-Cintrón, Madeline

AU - Chen, Tony

AU - Marcinek, David J.

AU - Dorn, Gerald W.

AU - Kang, Y. James

AU - Prolla, Tomas A.

AU - Santana, Luis F.

AU - Rabinovitch, Peter S.

PY - 2011/4/1

Y1 - 2011/4/1

N2 - Rationale: Mitochondrial dysfunction has been implicated in several cardiovascular diseases; however, the roles of mitochondrial oxidative stress and DNA damage in hypertensive cardiomyopathy are not well understood. Objective: We evaluated the contribution of mitochondrial reactive oxygen species (ROS) to cardiac hypertrophy and failure by using genetic mouse models overexpressing catalase targeted to mitochondria and to peroxisomes. Methods and results: Angiotensin II increases mitochondrial ROS in cardiomyocytes, concomitant with increased mitochondrial protein carbonyls, mitochondrial DNA deletions, increased autophagy and signaling for mitochondrial biogenesis in hearts of angiotensin II-treated mice. The causal role of mitochondrial ROS in angiotensin II-induced cardiomyopathy is shown by the observation that mice that overexpress catalase targeted to mitochondria, but not mice that overexpress wild-type peroxisomal catalase, are resistant to cardiac hypertrophy, fibrosis and mitochondrial damage induced by angiotensin II, as well as heart failure induced by overexpression of Gαq. Furthermore, primary damage to mitochondrial DNA, induced by zidovudine administration or homozygous mutation of mitochondrial polymerase γ, is also shown to contribute directly to the development of cardiac hypertrophy, fibrosis and failure. Conclusions: These data indicate the critical role of mitochondrial ROS in cardiac hypertrophy and failure and support the potential use of mitochondrial-targeted antioxidants for prevention and treatment of hypertensive cardiomyopathy.

AB - Rationale: Mitochondrial dysfunction has been implicated in several cardiovascular diseases; however, the roles of mitochondrial oxidative stress and DNA damage in hypertensive cardiomyopathy are not well understood. Objective: We evaluated the contribution of mitochondrial reactive oxygen species (ROS) to cardiac hypertrophy and failure by using genetic mouse models overexpressing catalase targeted to mitochondria and to peroxisomes. Methods and results: Angiotensin II increases mitochondrial ROS in cardiomyocytes, concomitant with increased mitochondrial protein carbonyls, mitochondrial DNA deletions, increased autophagy and signaling for mitochondrial biogenesis in hearts of angiotensin II-treated mice. The causal role of mitochondrial ROS in angiotensin II-induced cardiomyopathy is shown by the observation that mice that overexpress catalase targeted to mitochondria, but not mice that overexpress wild-type peroxisomal catalase, are resistant to cardiac hypertrophy, fibrosis and mitochondrial damage induced by angiotensin II, as well as heart failure induced by overexpression of Gαq. Furthermore, primary damage to mitochondrial DNA, induced by zidovudine administration or homozygous mutation of mitochondrial polymerase γ, is also shown to contribute directly to the development of cardiac hypertrophy, fibrosis and failure. Conclusions: These data indicate the critical role of mitochondrial ROS in cardiac hypertrophy and failure and support the potential use of mitochondrial-targeted antioxidants for prevention and treatment of hypertensive cardiomyopathy.

KW - angiotensin

KW - cardiomyopathy

KW - heart failure

KW - mitochondria

KW - reactive oxygen species

UR - http://www.scopus.com/inward/record.url?scp=79954694973&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79954694973&partnerID=8YFLogxK

U2 - 10.1161/CIRCRESAHA.110.232306

DO - 10.1161/CIRCRESAHA.110.232306

M3 - Article

C2 - 21311045

AN - SCOPUS:79954694973

VL - 108

SP - 837

EP - 846

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 7

ER -